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Abstract
Background: Angiostrongylus cantonensis (A. cantonensis) infection can lead to optic neuritis, retinal inflammation,
damage to ganglion cells, demyelination of optic nerve and visual impairment. Combined therapy of albendazole
and dexamethasone is a common treatment for the disease in the clinic, but it plays no role in vision recovery.
Therefore, it has been necessary to explore alternative therapies to treat this disease. Previous studies reported
the neuro-productive effects of two constituents of Danshen (a Chinese herb)-tanshinone II-A (TSII-A) and
cryptotanshinone (CPT), and this study aims to evaluate the impacts of TSII-A or CPT combined with albendazole
on optic neuritis caused by A. cantonensis infection in a murine model.
Methods: To assess the effects of TSII-A or CPT combined with albendazole on optic neuritis due to the infection,
mice were divided into six groups, including the normal control group, infection group and four treatment groups
(albendazole group, albendazole combined with dexamethasone group, albendazole combined with CPT group
and albendazole combined with TSII-A group). The infection group and treatment groups were infected with A.
cantonensisand the treatment groups received interventions from 14 dpi (days post infection), respectively. At
21 dpi, the visual acuity of mice in each group was examined by visual evoked potential (VEP). The pathologic
alteration of the retina and optic nerve were observed by hematoxylin and eosin (H&E) staining and transmission
electronic microscopy (TEM).
Results: Infection of A. cantonensis caused prolonged VEP latency, obvious inflammatory cell infiltration in the
retina, damaged retinal ganglions and retinal swelling, followed by optic nerve fibre demyelination and a
decreasing number of axons at 21 dpi. In treatment groups, albendazole could not alleviate the above symptoms;
albendazole combined with dexamethasone lessened the inflammation of the retina, but was futile for the other
changes; however, albendazole combined with CPT and albendazole combined with TSII-A showed obvious effects
on the recovery of prolonged VEP latency, destruction and reduction of ganglion cells, optic nerve demyelination
and axon loss. Compared with albendazole-CPT compound, albendazole combined with TSII-A was more effective.
Conclusions: The current study demonstrates that albendazole combined with TSII-A plays a more effective role in
treating optic neuritis caused by A. cantonensis in mice than with dexamethasone, as applied in conventional treatment,
indicating that albendazole combined with TSII-A might be an alternate therapy for this parasitic disease in the clinic.
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Background
Angiostrongyliasis is a food-borne parasitic disease
caused by Angiostrongylus cantonensis. The third-stage
larva of A. cantonensismainly invades the central nerve
system and causes meningitis, spinal meningitis, encephal-
itis, myelitis and optic neuritis [1–4]. There are ongoing
reports of optic neuritis cases caused by A. cantonensisin-
fection. In a previous review, we made an extensive litera-
ture survey on ocular angiostrongyliasis with 42 sporadic
cases [5]. Moreover, Punyagupta et al. [6] analysed the
clinical features of 484 cases of typical eosinophilic
meningitis and found that 16 % of patients had visual
impairment, while 12 % had an optic disc abnormality
such as papilledema and atrophy, which implied that the
actual incidence of ocular angiostrongyliasis is likely much
higher than commonly appreciated (1 %) [6].
Oral steroids such as dexamethasone combined with
an anti-helminthic agent like albendazole have been the
most effective and common therapy clinically so far for
the damage to vision caused by this parasite [7], for the
significant improvement of intraocular inflammation and
visual acuity. However, this treatment does not always
achieve complete recovery of vision, which severely in-
terferes with the quality of life of patients [8] and hence
leaves an unsolved problem for researchers nowadays.
Our previous study tried to explore the pathologic
changes and effective treatments for optic neuritis caused
by A. cantonensis infection in animal models. We consid-
ered BALB/c mice as an ideal model for A. cantonensis-in-
duced optic neuritis for the following representative
pathological changes: inflammatory cell infiltration in retina
and optic nerve adventitia followed by distinct optic nerve
fibre demyelination and retinal ganglion swelling. More-
over, tribendimidine (TBD) therapy can significantly ease
retina and optic nerve inflammation, but vision did not re-
cover owing to the ineffective rescue of the damaged gan-
glion cells and myelin sheath [9]. Besides, we also reported
thatalbendazole-dexamethasone compound, as the conven-
tional therapy, has little effect on the pathologic damage to
optic nerve caused by A. cantonensis in infected rats [10].
All the unsolved problems mentioned above have urged
us to prioritize research into a more effective treatment
for A. cantonensis-induced optic neuritis. In this study,
two constituents of Danshen (Salviamiltiorrhiza), tanshi-
none II-A (TSII-A) and cryptotanshinone (CPT), were
combined with albendazole separately to treat the disease.
Danshen is a type of traditional Chinese herb, which
has drawn extensive attention as an effective therapeutic
against a number of diseases including atherosclerosis,
hyperlipidemia, hypertension, stable angina pectoris,
myocardial infarction, coronary artery disease, diabetes
and metabolic syndrome, supported by published papers,
approved patents and clinical trials in the United States.
TSII-A and CPT are the most abundant and well-studied
constituents of Danshen, which exerts antioxidant and
anti-inflammatory effects on many experimental animal
models, achieving potential protective effects against
atherosclerosis, cardiac hypertrophy, cardiac fibrosis,
diabetes, neurodegenerative diseases, and various kinds of
cancers [11, 12]. Attributing to their neuro-protective
effect [13–15], they were applied in our study to protect
the damage of ganglion cells caused by A. cantonensis in
infected mice so as to rescue the loss of vision. Our results
showed TSII-A or CPT combined with albendazole was
more effective than the other two treatment groups, in-
cluding the traditional albendazole-dexamethasone group.
They could reverse the damage and loss of ganglion cells,
reduce the demyelination of optic nerve, and return the
number and diameter of nerve fibres to normal, and hence
significantly improved vision acuity. Between them,
TSII-A was more effective than CPT, indicating that
albendazole combined with TSII-A can be a more
effective therapeutic treatment than the albendazole-
dexamethasone compound to treat optic neuritis caused
by A. cantonensis and should be applied in clinic. Our
study provides an alternative medication therapy for optic
neuritis caused by A.cantonensis.
Methods
Infection of mice with larvae of A. cantonensis
BALB/c mice (20–40 g body weight) were purchased from
the animal centre laboratory at Sun Yat-sen University
(Guangzhou, China). The Institutional Animal Care and
Use Committee approved all animal procedures. The third
stage larvae (L3) of A. cantonensis were collected and used
to infect the mice as described in the methods section of
our previously published paper [8]. The animals were di-
vided into six groups: normal control group, infected
group, and four treatment groups (albendazole group,
albendazole combined with dexamethasone group, alben-
dazole combined with CPT group and albendazole com-
bined with TSII-A group). There were six animals in every
group. Except for the normal control group, the other five
groups were infected with 30 L3, respectively. After 14 dpi
(days post infection), the treatment groups were fed with
albendazole (20 mg/kg/d), albendazole combined with
dexamethasone (0.5 mg/kg/d), albendazole combined with
CPT (50 mg/kg/d) and albendazole combined with TSII-A
(50 mg/kg/d), respectively. The normal and infected
groups were treated with the same amount of DMSO as
control. All the medicines or DMSO were administered
via gastric gavage to mice once per day for 7 days.
Electrophysiological recordings
In consideration of the following VEP recording, all mice
in the six groups were anesthetized and secured to a
moveable platform at 21 dpi. In VEP recording, stainless
steel screws were implanted 3 mm lateral to the lambda
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and 5 mm behind the bregma. Reference electrodes were
placed 2 mm lateral to the lambda and 2 mm in front of
the bregma. Transient VEPs were evoked by single-
flash stimulation (1.3 Hz, 12 ms). VEP signals were
recorded by a commercial system (Roland Consult
GmbH, Brandenburg, Germany).
Histopathological observation
Following sacrifice of the mice in the six groups at 21
dpi by cervical dislocation, paraffin embedded sections
were prepared from isolated optic nerves and eyeballs.
Optic neuritis was detected by the presence of inflam-
matory cell infiltration on hematoxylin and eosin (H&E)
staining and observed by microscopy (Olympus, Japan).
Retina thickness was measured using Image Pro Plus 6.0
(Media Cybernetics, USA). Demyelination detection was
carried out using a 300 KV transmission electronic
microscope (FEI, USA) and the number and diameter of
axons were measured using Image Pro Plus 6.0.
Immunohistochemical analysis
Mice were anaesthetized and perfused with 4 % parafor-
maldehyde in PBS. Eyeballs of mice in every group were
fixed with 4 % paraformaldehyde overnight, equilibrated
in 15 % and then 30 % sucrose solutions in PBS. Later,
eyeballswere cut into15 μm thick sections at −20 °C and
mounted on glass slides. Sections were then blocked with
3 % bovine serum albumin (BSA) at room temperature for
1 h before incubation with rabbit anti-mouse Brn-3A
(1:125 dilution, Millipore, USA) monoclonal antibody in
1 % BSA at 37 °C for 1 h. Sections were washed three
times in PBS, incubated with fluorescein isothiocyanate
(TRITC)-labeled secondary antibody (Abcam, Cambridge,
UK), diluted 1:500 in 1 % BSA at 37 °C for 1 h, and
washed again in PBS. Then nuclei were stained with DAPI
(1:1,000 diluted, Beyotime Biotechnology, Haimen,
China) for 5 min. Specimens stained without the
primary antibody were used as negative controls. The sec-
tions were then observed under a confocal microscope.
Statistics
One-way ANOVA was used to compare VEP P2 latency
time, retinal thickness, axon numbers, diameter of optic
nerve fibres and ganglion cellcount among different
groups, and a p-value of less than 0.05 was considered
to be statistically significant. Statistics were performed
using IBM SPSS statistics 19 (SPSS Inc, USA).
Results
Albendazole combined with TSII-A (a Chinese herb
compound) has a curative effect on optic neuritis-induced
vision impairment caused by A. cantonensis
VEP measurements were performed to diagnose optic
neuritis in vivo. In the present study, P2 latency of VEP
of mice in the infection group became elongated at
21dpi (Fig. 1b, d) compared to normal control group
(Fig. 1a). After treatment with albendazole and conven-
tional albendazole-dexamethasoneprocedure, VEP of
infected mice did not significantly decrease (Fig. 1c, d).
Albendazole combined with CPT decreased the latency
of VEP slightly, but did not regain the normal level
(Fig. 1d, e). Nevertheless, albendazole combined with
TSII-A was able to reverse the damaged vision and
rehabilitate elongated P2 latency of VEP to basement
line value (Fig. 1d, f ).
Albendazole combined with TSII-Acan alleviate the
damage to ganglion cells
Histopathological examination showed inflammatory cell
infiltration in the ganglion cell layer (Fig. 2b1) and swollen
retina (Fig. 2b2) at 21 dpi. Albendazole applied alone
failed to diminish the inflammation but contrarily aggra-
vated the swelling of the retina (Fig. 2c1, g). It failed to
prevent the damage to the structure of ganglion cells,
(Fig. 2c2). Albendazole combined with dexamethasone
alleviated inflammation and swelling of the retina signifi-
cantly (Fig. 2d1, g), but did not show obvious curative
effects on the damaged ganglion cells (Fig. 2d2).
Albendazole combined with CPT showed a slight
anti-inflammatory effect on the retina (Fig. 2e1) and
can alleviate the damage to ganglion cells; however,
the cytoplasm swelling still existed (Fig. 2e2). On examin-
ing inflammatory changes, albendazole combined with
TSII-A group could not reduce inflammationof the retina
(Fig. 2f1), but could recover the damaged ganglion cell to
normal structure efficaciously (Fig. 2f2).
Albendazole combined with TSII-A can rescue the loss of
ganglion cells
The former experiment examined the pathological
changes of retina and ganglion cells before and after
treatment, indicating that TSII-A could achieve the best
protective effect towards the ganglion cell damage caused
by A. cantonensis compared with other groups. Next,
we made further efforts to evaluate the protective
effect of different therapies on ganglion cells by
immunofluorescence-oriented cytometry. Our results
demonstrated that A. cantonensis infection led to
noteworthy ganglion cell loss (Fig. 3b, g). Albendazole
or albendazole-dexamethasone treatment could not
rescue the loss of ganglion cells (Fig. 3c, d, g)
whereas albendazole combined with CPT (Fig. 3e, g)
and albendazole combined with TSII-A can both
effectively prevent the death of ganglion cells caused
by A. cantonensis, and the curative effect of the
former was more apparent (Fig. 3f, g).
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Albendazole combined with TSII-A can reverse the
damage to nerve fibres
The results of TEM showed that noteworthy demyelin-
ation appeared in the optic nerve (Fig. 4b), accompanied
by a reduction in the number of axons and an increased
diameter of myelin sheath (Fig. 4d, g) at 21 dpi. Although
albendazole can alleviate the demyelination, it cannot help
to regain the number of axons (Fig. 4d, g). Results from
the albendazole combined with dexamethasone treatment
group can also mitigate demyelination and axon destruc-
tion, and can increase the number of axons to some extent
but not to the normal level (Fig. 4d, g). However, in the
albendazole-CPT or albendazole-TSII-A treated group,
both the structure of the myelin sheath and axon and the
number of axons regained normal levels (Fig. 4e, f ), and
the latter was more effective (Fig. 4g). These results indi-
cated that albendazole combined with TSII-A could not
only alleviate the demyelination of the optic nerve, but
also contributed to the remyelination of axons by increas-
ing their number.
Discussion
In this study, we compared the compound of albendazole
and the constituents of Danshen (one Chinese herb),
TSII-Aand CPT, in the treatment of optic neuritis caused
by A. cantonensis. Previous studies showed that Danshen
derivatives, TSII-A and CPT, exert antioxidant and anti-
inflammatory actions in many experimental animal
models. In addition, neuroprotective effects of TSIIA have
been reported in rats, mice and in vitro assays. As a result,
we chose TSII-A combined with albendazole to treat the
disease and expected to attain a better therapeutic effect
compared with the conventional albendazole - dexametha-
sone combination therapy. Our results showed that alben-
dazole combined with TSII-A may be preferable to other
therapeutic methods in pathologic change improvement
and visual acuity recovery. The evidence was as follows.
Firstly, the detection of VEP demonstrated that TSII-A
contributed to the vision recovery in optic neuritis
caused by A. cantonensis. VEP is the most sensitive
method to examine optic neuropathy and is applied as
an important index to diagnose optic neuritis and evalu-
ate the functional status from retina ganglion cells to
optic cortex [16]. Moreover, it may be used as a real
measurement of demyelination in the rat model of optic
neuritis [17]. In the present study, VEP latency of mice
at 21 dpi appeared obviously delayed, which may have
intimate correlation with the damage of optic nerve
fibres and ganglion cells. While there was no obvious
VEP recovery with sole albendazole treatment and
Fig. 1 Data are mean ± SEM for P2 latency alterations of VEP in in different groups. a–f: P2 latency of VEP. Black arrow indicates P2 latency (ms).
a: Normal group. b: Infected group by A. cantonensis (21 dpi). P2 latency is prolonged (>100 ms, ↓points). c: Albendazole (AB) treatment for
7 days after 14 dpi with A. cantonensis. P2 latency still is prolonged (>100 ms, ↓points). d: Albendazole combined with Dexamethasone (De)
treatment for 7 days after 14dpi with A. cantonensis. P2 latency is still prolonged (>100 ms, ↓points). e: Albendazole combined with CPT
treatment for 7 days after 14 dpi with A. cantonensis. P2 latency recovered to normal. f: Albendazole combined with TSII-A treatment for 7 days
after 14 dpi with A. cantonensis. P2 latency recovered to normal. g: Data are mean ± SEM of P2 latency of mice in different treatment groups for
7 days after 14 dpi with A. cantonensis. *Statistically significant when compared with normal control (P < 0.05); #Statistically significant when
compared with 21 dpi with A. cantonensis, n = 5 per group, P < 0.05
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albendazole combined with dexamethasone treatment,
VEP latency returned to normal in CPT and TSII-A
combined with albendazole treatment groups. The
results also indicate that TSII-A can rescue the function
of ganglion cells and parts of optic nerve fibres, which
have been damaged by the infection with A. cantonensis.
Secondly, the results of immunofluorescence also
proved the curative effect of albendazole combined with
TSII-A treatment in optic neuritis caused by A. cantonensis.
At 21 dpi, the number of ganglion cells seen in the
infection group decreased sharply compared to the
normal control group. Ganglion cells are the most
important neurons in the retina and their axons form
the optic nerve. The damage of ganglion cells will
cause serious vision impairment [18]. Sole albendazole
treatment and albendazole combined with dexamethasone
treatment increased the ganglion cell number slightly,
whereas CPT or TSII-A combined with albendazole treat-
ment were shown to help almost regain the initial number
of ganglion cells, and the latter was more effective, indicat-
ing that albendazole combined with TSII-A can rescue the
loss of ganglion cells caused by A. cantonensis infection
significantly. Previous studies showed TSII-A played a
vital role in protecting neurons such as dopaminergic neu-
rons and hippocampal neurons [19, 20], and may inhibit
thebeta-amyloid-induced toxicity in rat cortical neurons
[21, 22]. In addition, TSII-A also has a protective effect on
the cranial nerves when administered during the initial
stages of cerebral ischemia [14]. Our results indicated
TSII-A can improve ganglion cell impairment caused by
A. cantonensis, however, the mechanisms involved need to
be further explored.
Fig. 2 The alteration of mouse retina and ganglion cells before and after treatment regimen following infection with A. cantonensis. a1-f1: retina
in different treatment groups with HE staning. bar = 100 μm.↑ points ganglion cell layer of retina. a2-f2: Electron microscopy images of ganglion
cells in different treatment groups. ↓ points cytoplasm of ganglion cells; ▲ points the nucleusof ganglion cells. bar = 1 μm. a1-a2: retina and
ganglion cell in normal group. There was a layer of ganglion cells (↑ in A1). The cytoplasm and nucleus of ganglion cells were intact (↓ and▲ in
A2). b1-b2: retina and ganglion cell in groups infected with A. cantonensis at 21 dpi. The ganglion cell layer showed inflammatory cell infiltration
(↑ in B1). Swelling was pronounced in cytoplasm of ganglion cells (↓in B2) and nucleus diminished. c1-c2: Albendazole (AB) treatment for 7 days
after 14 dpi with A. cantonensis. Inflammation was alleviated in ganglion cell layer of retina (↑ in C1). Swelling can still be observed in cytoplasm
of ganglion cell (↓ in C2) with an intact nuclear as usual (▲ in C2). d1-d2: Albendazole combined with Dexamethasone treatment (AB + De) for
7 days after 14 dpi with A. cantonensis. The inflammation of the retina almost resolved (↑ in D2). Swelling of ganglion cytoplasm relieved (↓ in
C2). The nucleus was still obviously observed (▲ in D2). e1-e2: Albendazole combined with CPT (AB + CPT)treatment for 7 days after 14 dpi with
A. cantonensis. Inflammation was alleviated in ganglion cell layer of retina (↑ in E1). Swelling decreased greatly in cytoplasm of ganglion cell
(↓ in E2). f1-f2: Albendazole combined with TSII-A (AB + TSII-A) treatment for 7 days after 14 dpi with A. cantonensis. Inflammation was alleviated
slightly in ganglion cell layer of retina (↑ in F1). Swelling diminished in cytoplasm of ganglion cell (↓ in F2) and the cells regained normal structure
as in A2. g: Retinal thickness measured under a light microscope in normal group, 21 dpi infection group, albendazole treatment group
(AB), albendazole combined with dexamethasone (AB + De) treatment group, albendazole combined with CPT (AB + CPT) treatment and albendazole
combined with TSII-A (AB + TSII-A) treatment group. Data are mean ± SEM. *Statistically significant when compared with control (0 dpi) (P < 0.05);
# Statistically significant when compared with 21 dpi (P < 0.05)
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Finally, the present study has clearly shown that alben-
dazole combined with TSII-A group rescued the damaged
ganglion cells and optic nerves. The infection group
showed severe retinal inflammation, ganglion cell destruc-
tion and optic nerve demyelination, followed by decreas-
ing axon number and swelling of nerve fibres, which
indicate that A. cantonensis can definitely cause optic
neuritis and structural alteration of retina and optic nerve
[9]. Sole albendazole treatment cannot improve the
inflammation or damaged ganglion cells, but on the con-
trary aggravated the inflammation of eyes due to thick-
ened retina. The reason may be that the decomposition
debris of dead worms killed by albendazole leads to an im-
mune reaction of hosts [23], and enhances the inflamma-
tion of the brain, which spreads into the eyes through the
optic nerve. Moreover, it was either ineffective to lessen
the damage to the optic nerve because it did not increase
the number of axons in the optic nerve compared with
the untreated group. Albendazole combined with dexa-
methasone alleviated inflammation of retina absolutely,
but could not recover the damage to the retina and optic
nerve, possibly because of the anti-inflammatory effect of
dexamethasone which is not potent enough to protect
ganglion cells and optic nerve. In contrast, the treatment
with TSII-A or CPT combined with albendazole signifi-
cantly improved ganglion cells damage and optic nerve
demyelination. The inflammation of the retina did not
completely recover after treatment with TSII-A or CPT
combined with albendazole, but the structure of ganglion
cells recovered well, and the number of axons in the optic
Fig. 3 TSII-A promotes RGC survival of mice infected with A. cantonensis. a-f: Immunofluorescence reinforced the image of RGC cells labeled with
Brn-3A (Green). Scale bar = 100 μm. a Normal control. b: Untreated mice infected with A. cantonensis (21 dpi). c: Albendazole (AB) for 7 days after
14 dpi with A. cantonensis. d: Albendazole combined with Dexamethasone (AB + De) for 7 days after 14 dpi with A. cantonensis. e: Albendazole
combined with CPT (AB + CPT) for 7 days after 14 dpi with A. cantonensis. f: Albendazole combined with TSII-A (AB + TSII-A) for 7 days after 14 dpi
with A. cantonensis. g: Data are mean ± SEM of ganglion cell numbers in normal group, untreated group for 21 dpi with A. cantonensis, and
treated group for 7 days after 14 dpi with A. cantonensis infection, respectively. *Statistically significant when compared with control (0 dpi);
# statistically significant when compared with 21 dpi; △ statistically significant when compared with albendazole treatment group,▲ statistically
significant when compared with Albendazole combined with Dexamethasone treatment group; N = 3 coverslips per group, with 5fields analyzed
per coverslip, P < 0.05
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nerve were back to normal, especially in the TSII-A
treated group, indicating that albendazole combined with
TSII-A is a more efficacious therapy to protect and rescue
the damage of the retina and optic nerve in optic neuritis
caused by A. cantonensis. Up to now, it has been the first
time that TSII-A has been reported for the treatment of
optic nerve demyelination.
Conclusion
In conclusion, the present study suggests that TSII-A
might be applied as a neurotrophic drug combined with
albendazole to treat optic neuritis caused by A. canto-
nensis, and this method is far more efficient than the
conventional albendazole - dexamethasone compound,
which should be taken into consideration as a highly
potential alternative therapy in treating this parasite-
induced optic neuritis.
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